Biomaterial Database

Inhibitory effect of (+)threo-3,4-dihydroxy-phenylserine (DOPS) on decarboxylation of (-)threo-dops. 1976

C Inagaki, and H Fujiwara, and C Tanaka

UI	MeSH Term	Description	Entries
D007536	Isomerism	The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)	Isomerisms
D007668	Kidney	Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.	Kidneys
D008297	Male		Males
D003653	Decarboxylation	The removal of a carboxyl group, usually in the form of carbon dioxide, from a chemical compound.	Decarboxylations
D000818	Animals	Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.	Animal,Metazoa,Animalia
D012694	Serine	A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.	L-Serine,L Serine
D013997	Time Factors	Elements of limited time intervals, contributing to particular results or situations.	Time Series,Factor, Time,Time Factor
D015103	Droxidopa	A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION.	3,4-Dihydroxyphenylserine,3,4-threo-DOPS,DL-threo-3,4-Dihydroxyphenylserine,Droxidopa, (DL-Tyr)-Isomer,erythro-3,4-Dihydroxyphenylserine,threo-DOPS,3,4 Dihydroxyphenylserine,3,4 threo DOPS,DL threo 3,4 Dihydroxyphenylserine,erythro 3,4 Dihydroxyphenylserine,threo DOPS
D051381	Rats	The common name for the genus Rattus.	Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

C Inagaki, and H Fujiwara, and C Tanaka

Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.

March 1986, Naunyn-Schmiedeberg's archives of pharmacology,

C Inagaki, and H Fujiwara, and C Tanaka

Memory effect of DL-threo-3,4-dihydroxyphenylserine (DOPS) in human Korsakoff's disease.

January 1988, Psychopharmacology,

C Inagaki, and H Fujiwara, and C Tanaka

Midodrine hydrochloride and L-threo-3,4-dihydroxy-phenylserine preserve cerebral blood flow in hemodialysis patients with orthostatic hypotension.

February 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,

C Inagaki, and H Fujiwara, and C Tanaka

Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.

March 1990, Japanese journal of pharmacology,

C Inagaki, and H Fujiwara, and C Tanaka

Inhibitory effect of N,O-acil-threo-DL-phenylserine derivatives on rat adjuvant arthritis.

December 2005, Die Pharmazie,

C Inagaki, and H Fujiwara, and C Tanaka

Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).

January 1988, Life sciences,

C Inagaki, and H Fujiwara, and C Tanaka

[Inhibitory effects of L-threo-DOPS on electroshock seizure in mice].

June 1989, No to shinkei = Brain and nerve,